Sirnaomics
Manufacturing · Maryland, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
20511 Seneca Meadows Pkwy Ste 200, Germa...Phone Number
(301) 740-1730Website
www.sirnaomics.comRevenue
<$5 MillionStock Symbol
2257Industry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Sirnaomics
With a strong presence in both Asia and the U.S., we are discovering and developing innovative drugs for indications with significant unmet medical needs and large market opportunities. We have built a professional international team for the discovery and development of RNAi therapeutics and mRNA vaccines and therapeutics, based on our proprietary drug delivery technology platforms.Explore more
Sirnaomics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sirnaomics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Sirnaomics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Sirnaomics had a recent Job posting/layoffs
Sirnaomics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Sirnaomics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Sirnaomics
Product Launch: Get notified when Sirnaomics launches new products
Funding: Get notified immidiatlly once Sirnaomics has new funding data
Earning: See what the market has to say on Sirnaomics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Sirnaomics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Sirnaomics
Compare insights from companies similar to Sirnaomics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sirnaomics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sirnaomics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sirnaomics.
Sirnaomics financials insights
Gather financial insights about Sirnaomics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series B
$25M
2019
Series C
$47M
2020
Debt
$350K
Series D
$105M
2021
Debt
$705K
Series E
$105M
Sirnaomics Tech Stack
A closer look at the technologies used by Sirnaomics
Most Recent Scoops
Funding
Funding
Event
Events, Engineering, Research & Development, Training, Machine Learning, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Chemical Engineering, Artificial Intelligence, Clinical Operations, Healthcare Technology, HR Operations, Operations
Executive Move
Executive Moves, Board of Directors
Left Company
Executive Move
Executive Moves, Left Company, Board of Directors
Left Company
Executive Move
Executive Moves, Left Company
Sirnaomics News & Media
Sirnaomics Announces Strategic Equity Investment by Bloomage Biotech to Jointly Advance Next-Generation Life Science Pipelines
HONG KONG, Sept. 7, 2025 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", together with its subsidiaries, the "Group" or "Sirnaomics"; Stock Code: 2257), a leading biopharmaceutical company in discovery and development of advanced RNAi therapeutics, today announced that it has entered into a strategic investment agreement with Bloomage Biotech (stock code: 688363.SH) through its wholly-owned subsidiary, Bloomage Biotechnology (Hong Kong) Limited. Under the terms of the agreement, Bloomage BiotechSirnaomics Ltd. Announces Leadership Changes - TipRanks.com
Sirnaomics Ltd. (HK:2257) has released an update. Sirnaomics Ltd. has announced the retirement of Dr. Yang Lu from his roles as Chairman, President, and Chief Scien...Sirnaomics Has Been Subscribed for 17,527,696 Subscription Shares, New Capital Injection to Promote Business Growth and Development
HONG KONG, GERMANTOWN, Md., and SUZHOU, China,, Oct. 4, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", together with its subsidiaries, the "Group" or "Sirnaomics"; stock code: 2257.HK), a leading biopharmaceutical company engaged in the discovery and development of advanced RNAi...Sirnaomics Announces Demonstration of a Novel Mechanism of Action of Its siRNA ...
HONG KONG, GERMANTOWN, Md., and SUZHOU, China, Sept. 19, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the 'Company', Stock Code: 2257, together with its subsidiaries, the 'Group' or 'Sirnaomics'), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced that the company in collaboration with Dr. Mark Nestor's team from the Center for Clinical and Cosmetic Research in Miami Florida has jointly published a major breakthrough for its novel si
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sirnaomics
Sign Up For FreeTo access detailed company insights
With a strong presence in both Asia and the U.S., we are discovering and developing innovative drugs for indications with significant unmet medical needs and large market opportunities. We have built a professional international team for the discovery and development of RNAi therapeutics and mRNA vaccines and therapeutics, based on our proprietary... Read More
